The Utility of Intraoperative Lateral Spread Recording in Microvascular Decompression for Hemifacial Spasm: A Systematic Review and Meta-Analysis

Neurosurgery ◽  
2021 ◽  
Vol 89 (Supplement_2) ◽  
pp. S23-S23
Author(s):  
Parthasarathy D Thirumala ◽  
Ahmed M Altibi ◽  
Robert Chang ◽  
Eyad E Saca ◽  
Pragnya Iyengar ◽  
...  
Neurosurgery ◽  
2020 ◽  
Vol 87 (5) ◽  
pp. E598-E599
Author(s):  
Robert Chang ◽  
Rajiv Reddy ◽  
Ahmed M Altibi ◽  
Pragnya Iyengar ◽  
Katherine Anetakis ◽  
...  

2018 ◽  
Vol 128 (1) ◽  
pp. 193-201 ◽  
Author(s):  
Jesse D. Lawrence ◽  
Andrew M. Frederickson ◽  
Yue-Fang Chang ◽  
Patricia M. Weiss ◽  
Peter C. Gerszten ◽  
...  

OBJECTIVEHemifacial spasm (HFS) is a movement disorder characterized by involuntary spasms of the facial muscles, and it can negatively impact quality of life (QOL). This retrospective study and systematic review with meta-analysis was conducted to investigate the QOL in patients with HFS following intervention with microvascular decompression (MVD) and botulinum toxin (BT).METHODSIn the retrospective analysis, a QOL questionnaire was administered to all patients undergoing MVD performed by a single surgeon. The QOL questionnaire included unique questions developed based on the authors' experience with HFS patients in addition to the health-related QOL HFS-8 questionnaire. The authors also report on a systematic review of the English literature providing outcomes and complications in patients with HFS undergoing treatment with either MVD or BT.RESULTSRegarding the retrospective analysis, 242 of 331 patients completed the questionnaire. The mean score of the 10 QOL questions improved from 22.78 (SD 9.83) to 2.17 (SD 5.75) following MVD (p < 0.001). There was significant improvement across all subscales of the questionnaire between pre- and postoperative responses (p < 0.001). Regarding the systematic review, it is reported that approximately 90% of patients undergoing MVD for HFS experience a complete recovery from symptoms, whereas the mean peak improvement of symptoms following treatment with BT is 77%. Furthermore, patients undergoing MVD reported a greater improvement in the mean supplemental index of QOL as compared with patients receiving BT therapy.CONCLUSIONSMicrovascular decompression offers a significant improvement in QOL in well-selected patients suffering from HFS, and may offer an increased benefit for QOL over BT injections.


2009 ◽  
Vol 27 (4) ◽  
pp. E10 ◽  
Author(s):  
Raymond F. Sekula ◽  
Sanjay Bhatia ◽  
Andrew M. Frederickson ◽  
Peter J. Jannetta ◽  
Matthew R. Quigley ◽  
...  

Object In this paper, the authors' goal was to determine the utility of monitoring the abnormal muscle response (AMR) or “lateral spread” during microvascular decompression surgery for hemifacial spasm. Methods The authors' experience with AMR as well as the data available in the English-language literature regarding resolution or persistence of AMR and the resolution or persistence of hemifacial spasm at follow-up was pooled and subjected to a meta-analysis. Results The pooled OR revealed by the meta-analysis was 4.2 (95% CI 2.7–6.7). The chance of a cure if the AMR was abolished during surgery was 4.2 times greater than if the lateral spread persisted. Conclusions The AMR should be monitored routinely in the operating room, and surgical decision-making in the operating room should be augmented by the AMR.


2020 ◽  
Vol 139 ◽  
pp. e383-e390
Author(s):  
Katherine Holste ◽  
Ronald Sahyouni ◽  
Zoe Teton ◽  
Alvin Y. Chan ◽  
Dario J. Englot ◽  
...  

Neurosurgery ◽  
2020 ◽  
Vol 87 (4) ◽  
pp. E473-E484 ◽  
Author(s):  
Parthasarathy D Thirumala ◽  
Ahmed M Altibi ◽  
Robert Chang ◽  
Eyad E Saca ◽  
Pragnya Iyengar ◽  
...  

Abstract BACKGROUND Microvascular decompression (MVD) is the surgical treatment of choice for hemifacial spasm (HFS). During MVD, monitoring of the abnormal lateral spread response (LSR), an evoked response to facial nerve stimulation, has been traditionally used to monitor adequacy of cranial nerve (CN) VII decompression. OBJECTIVE To assess the utility of LSR monitoring in predicting spasm-free status after MVD postoperatively. METHODS We searched PubMed, Web of Science, and Embase for relevant publications. We included studies reporting on intraoperative LSR monitoring during MVD for HFS and spasm-free status following the procedure. Sensitivity of LSR, specificity, diagnostic odds ratio, and positive predictive value were calculated. RESULTS From 148 studies, 26 studies with 7479 patients were ultimately included in this meta-analysis. The final intraoperative LSR status predicted the clinical outcome of MVD with the following specificities and sensitivities: 89% (0.83- 0.93) and 40% (0.30- 0.51) at discharge, 90% (0.84-0.94) and 41% (0.29-0.53) at 3 mo, 89% (0.83-0.93) and 40% (0.30-0.51) at 1 yr. When LSR persisted after MVD, the probability (95% CI) for HFS persistence was 47.8% (0.33-0.63) at discharge, 40.8% (0.23-0.61) at 3 mo, and 24.4% (0.13-0.41) at 1 yr. However, when LSR resolved, the probability for HFS persistence was 7.3% at discharge, 4.2% at 3 mo, and 4.0% at 1 yr. CONCLUSION Intraoperative LSR monitoring has high specificity but modest sensitivity in predicting the spasm-free status following MVD. Persistence of LSR carries high risk for immediate and long-term facial spasm persistence. Therefore, adequacy of decompression should be thoroughly investigated before closing in cases where intraoperative LSR persists.


2018 ◽  
Vol 129 ◽  
pp. e109 ◽  
Author(s):  
Parthasarathy Thirumala ◽  
Robert Chang ◽  
Pragyna Iyengar ◽  
Rajiv Reddy ◽  
Ahmed M. Altibi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document